Sort
25,944 grants matching “neurodegeneration”
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,849,047Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2025 · AG
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
$1,848,870Jeffery W Kelly · Scripps Research Institute, The · P01 · FY2013 · AG
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
$1,846,196Carlos Cruchaga · Washington University · R01 · FY2022 · AG
Behavioral and Neural Plasticity in the Aged
$1,845,654Carl W Cotman · University Of California-Irvine · P01 · FY2014 · AG
Parkinson's Disease and Dementia
$1,845,465John Q. Trojanowski · University Of Pennsylvania · P50 · FY2011 · NS
Behavior and Neural Plasticity in the Aged
$1,843,972Carl W Cotman · University Of California-Irvine · P01 · FY2008 · AG
Organization and Dynamics of Endomembrane Pathways and Organelles
$1,842,743Jennifer Lippincott-Schwartz · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Behavior and Neural Plasticity in the Aged
$1,840,163Carl W Cotman · University Of California-Irvine · P01 · FY2012 · AG
Molecular Pathogenesis of Age-Dependent CNS Degeneration
$1,839,930Stanley B Prusiner · University Of California, San Francisco · P01 · FY2006 · AG
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,834,889Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · NS
CONNECT-TBI
$1,834,861Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2020 · NS
Molecular Analysis Of Human Hereditary Deafness
$1,834,765Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,834,302Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · NS
Rapireon, a new macrocycle molecular glue that selectively activates the nuclease activity of IRE1
$1,830,581Jun O. Liu · Johns Hopkins University · RF1 · FY2024 · NS
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
$1,827,905Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2025 · NS
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
$1,827,156Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2023 · NS
MAYO ALZHEIMERS DISEASE RESEARCH CENTER
$1,824,022Mayo Clinic Coll Of Medicine, Rochester · P50 · FY2002 · AG
SPOP drives neurodegenerative tauopathy
$1,823,353Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · RF1 · FY2023 · AG
Alzheimer's Disease Research Center (ADRC) of the University of California Irvine
$1,822,270Carl W Cotman · University Of California-Irvine · P50 · FY2009 · AG
Structure and Genesis of tau Aggregates
$1,821,723Jeff A Kuret · Ohio State University · RF1 · FY2022 · AG
Discovery of Novel Drugs that Increase Tau Clearance to Treat Alzheimer's Disease
$1,818,228Steven M Finkbeiner · J. David Gladstone Institutes · RF1 · FY2018 · AG
Behavioral and Neural Plasticity in the Aged
$1,818,194Carl W Cotman · University Of California-Irvine · P01 · FY2016 · AG
ADP-ribosylation Cycles
$1,818,115Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Genetic Architecture of Alzheimerâs disease Proteinopathies
$1,817,608M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Boston University Alzheimer's Disease Center
$1,815,000Neil W. Kowall · Boston University Medical Campus · P30 · FY2018 · AG